Catherine Rampell is an opinion columnist at The Washington Post. She frequently covers economics, public policy, immigration and politics, with a special emphasis on data-driven journalism.

Neurocrine Biosciences Inc. has appointed Andrew Ratz, Ph.D. as Senior Vice President of Drug Development, Delivery and Device. In this role, Ratz will lead the transformation of Neurocrine’s ...

If you’re on the fence about investing in AbbVie Inc., Neurocrine Biosciences or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...

SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that Andrew Ratz, Ph.D., has joined the company as Senior Vice President of Drug Development ...

SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has sponsored a supplement in The Journal of Clinical Endocrinology & Metabolism (JCEM) focusing on classic congenital adrenal hyperplasia ...

Joseph I. Cassilly, who served as Harford County’s state’s attorney for 36 years, died Friday morning of cardiac arrest at his home. He was 74. Cassilly, the older brother of current Harford ...

This week’s “Come, Follow Me” study guide covers Doctrine and Covenants 2 and Joseph Smith—History 1:27-65, which includes the prophecy that “the hearts of the children shall turn to their fathers” ...

On Thursday, Oppenheimer reiterated its Outperform rating on shares of Neurocrine (NASDAQ:NBIX) Biosciences (NASDAQ:NBIX), currently trading at $141.24, with a steady price target of $192.00. The firm ...